Matches in Wikidata for { <http://www.wikidata.org/entity/Q63012282> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q63012282 description "clinical trial" @default.
- Q63012282 description "ensayu clínicu" @default.
- Q63012282 description "klinisch onderzoek" @default.
- Q63012282 description "клінічне випробування" @default.
- Q63012282 name "A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients." @default.
- Q63012282 type Item @default.
- Q63012282 label "A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients." @default.
- Q63012282 prefLabel "A Clinical Study to Evaluate the Efficacy and Safety of MIN-102 (IMP) in Male AMN Patients." @default.
- Q63012282 P1132 Q63012282-6E8A302D-4F87-4C65-9D1B-C25C2656834C @default.
- Q63012282 P1476 Q63012282-5F3791EC-59DA-401A-8F36-E608796FE65F @default.
- Q63012282 P17 Q63012282-1BB196F2-57C6-48D4-8F7A-B2F46D283EBD @default.
- Q63012282 P17 Q63012282-2679C342-0F31-4B1F-A81F-064C1B2AAC3D @default.
- Q63012282 P17 Q63012282-33243F67-8694-4D7C-AACE-3D826DCC6E9E @default.
- Q63012282 P17 Q63012282-3FD7C9EB-10F4-4CCD-8317-07B50707BFF9 @default.
- Q63012282 P17 Q63012282-5ECFFD04-1624-45C6-8AF5-5E8F75720E92 @default.
- Q63012282 P17 Q63012282-8C5A39D2-A54D-4AFA-94DD-AC0B0CDD3179 @default.
- Q63012282 P17 Q63012282-AC3F69F3-43A0-495A-8539-448B324BDB6A @default.
- Q63012282 P17 Q63012282-CA6F614E-1E7B-4ACA-B7F8-AF11D4AE8741 @default.
- Q63012282 P1813 Q63012282-0A9D8187-4493-43F3-B64A-D96BC01D13D4 @default.
- Q63012282 P2899 Q63012282-5FF45ABD-FE3D-4C0E-8E0A-1AAB01377E78 @default.
- Q63012282 P3098 Q63012282-7488283D-0655-4EC3-97C9-6169E2017B50 @default.
- Q63012282 P31 Q63012282-1F2FB8FA-1E28-478A-8002-0B941B035B5F @default.
- Q63012282 P4135 Q63012282-929CB5BB-8F4B-4797-824B-90F1786C1823 @default.
- Q63012282 P580 Q63012282-55405E36-08D4-4E82-8DF4-86D84590CD95 @default.
- Q63012282 P582 Q63012282-4EAE2B02-A391-4DC6-B317-3BFA3E5261E8 @default.
- Q63012282 P6099 Q63012282-7CD12868-2352-4DA0-87EA-9A30F90273FB @default.
- Q63012282 P6099 Q63012282-E7F46426-C3A1-4C89-AC2E-9F639805AA92 @default.
- Q63012282 P6153 Q63012282-C35D7353-8EE1-4490-A5C2-56B74338454C @default.
- Q63012282 P8363 Q63012282-805E1319-60D2-4565-AE41-51B558EAEEB2 @default.
- Q63012282 P1132 "+105" @default.
- Q63012282 P1476 "A Randomized, Double-blind, Placebo-controlled, Multinational, Multicenter Study With Open-label Treatment Extension to Assess the Effect of MIN-102 (IMP) on the Progression of Adrenomyeloneuropathy in Male Patients With X-linked Adrenoleukodystrophy" @default.
- Q63012282 P17 Q142 @default.
- Q63012282 P17 Q145 @default.
- Q63012282 P17 Q183 @default.
- Q63012282 P17 Q28 @default.
- Q63012282 P17 Q29 @default.
- Q63012282 P17 Q30 @default.
- Q63012282 P17 Q38 @default.
- Q63012282 P17 Q55 @default.
- Q63012282 P1813 "Advance" @default.
- Q63012282 P2899 "+18" @default.
- Q63012282 P3098 "NCT03231878" @default.
- Q63012282 P31 Q30612 @default.
- Q63012282 P4135 "+65" @default.
- Q63012282 P580 "2017-12-08T00:00:00Z" @default.
- Q63012282 P582 "2020-10-01T00:00:00Z" @default.
- Q63012282 P6099 Q42824440 @default.
- Q63012282 P6099 Q42824827 @default.
- Q63012282 P6153 Q126412 @default.
- Q63012282 P8363 Q78089383 @default.